These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9989741)

  • 1. Interferon beta treatment for multiple sclerosis.
    Goodin DS
    Lancet; 1999 Feb; 353(9151):495-6; author reply 497-8. PubMed ID: 9989741
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon beta treatment for multiple sclerosis.
    Galazka A
    Lancet; 1999 Feb; 353(9151):495; author reply 497-8. PubMed ID: 9989740
    [No Abstract]   [Full Text] [Related]  

  • 3. Interferon beta treatment for multiple sclerosis.
    O'Connor P
    Lancet; 1999 Feb; 353(9151):496; author reply 497-8. PubMed ID: 9989742
    [No Abstract]   [Full Text] [Related]  

  • 4. Interferon beta treatment for multiple sclerosis.
    Herndon RM
    Lancet; 1999 Feb; 353(9151):494-5; author reply 497-8. PubMed ID: 9989739
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferon beta-1A for relapsing multiple sclerosis.
    Med Lett Drugs Ther; 1996 Jul; 38(979):63-4. PubMed ID: 8692073
    [No Abstract]   [Full Text] [Related]  

  • 6. Interferon beta treatment in multiple sclerosis: the European clinical trials.
    Comi G; Martinelli V; Filippi M
    Mult Scler; 1996 Jul; 1(6):317-20. PubMed ID: 9345407
    [No Abstract]   [Full Text] [Related]  

  • 7. New treatments for multiple sclerosis.
    McDonald WI
    BMJ; 1995 Feb; 310(6976):345-6. PubMed ID: 7866205
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized, comparative study of interferon beta-1a treatment regimens in MS: the EVIDENCE trial.
    Byrne E
    Neurology; 2003 Jun; 60(11):1872; author reply 1872-3. PubMed ID: 12796564
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferon beta-1A for multiple sclerosis.
    Drug Ther Bull; 1998 Jan; 36(1):7-8. PubMed ID: 9614724
    [No Abstract]   [Full Text] [Related]  

  • 10. [Multiple sclerosis].
    Tanosaki M; Matsunaga M
    Nihon Rinsho; 2004 May; 62 Suppl 5():586-9. PubMed ID: 15197989
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant human interferon beta in the treatment of relapsing-remitting and secondary progressive multiple sclerosis.
    Sandberg-Wollheim M; Hommes OR; Hughes RA; Paty DW; Abdul-Ahad AK
    Mult Scler; 1995; 1 Suppl 1():S48-50. PubMed ID: 9345399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of multiple sclerosis with interferons].
    Nogales-Gaete J; Arriagada C
    Rev Med Chil; 1996 May; 124(5):597-604. PubMed ID: 9035514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon beta-1b in secondary progressive multiple sclerosis--outline of the clinical trial.
    Polman CH; Dahlke F; Thompson AJ; Ghazi M; Kappos L; Miltenburger C; Pozilli C
    Mult Scler; 1995; 1 Suppl 1():S51-4. PubMed ID: 9345400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferons in the treatment of multiple sclerosis: errors and misrepresentations.
    Herndon RM
    Arch Neurol; 2000 Mar; 57(3):426-7. PubMed ID: 10714676
    [No Abstract]   [Full Text] [Related]  

  • 15. [Interferon therapy of multiple sclerosis].
    Jensen D
    Tidsskr Nor Laegeforen; 1999 Sep; 119(21):3142-5. PubMed ID: 10522481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early treatment of multiple sclerosis with Rebif (recombinant human interferon beta): design of the study.
    Comi G; Barkhof F; Durelli L; Edan G; Fernandez O; Filippi M; Hartung HP; Hommes OR; Seeldrayers P; Soelberg-Sorensen P
    Mult Scler; 1995; 1 Suppl 1():S24-7. PubMed ID: 9345394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of multiple sclerosis in children: a European view.
    Ghezzi A; Banwell B; Boyko A; Amato MP; Anlar B; Blinkenberg M; Boon M; Filippi M; Jozwiak S; Ketelslegers I; Kornek B; Lim M; Lindstrom E; Nadj C; Neuteboom R; Rocca MA; Rostasy K; Tardieu M; Wassmer E; Catsman-Berrevoets C; Hintzen R
    Mult Scler; 2010 Oct; 16(10):1258-67. PubMed ID: 20685764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
    Lancet; 1998 Nov; 352(9139):1498-504. PubMed ID: 9820297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon beta-1a and beta-1b for treatment of multiple sclerosis.
    Benatar M
    Lancet; 2002 Nov; 360(9343):1428; author reply 1428-9. PubMed ID: 12424021
    [No Abstract]   [Full Text] [Related]  

  • 20. Interferon beta in multiple sclerosis.
    Napier JC
    Lancet; 1999 Aug; 354(9177):512; author reply 512-3. PubMed ID: 10465197
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.